Literature DB >> 2380843

Clearance of toxic metabolites during therapy for inborn errors of metabolism.

E Ring, G Zobel, S Stöckler.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2380843     DOI： 10.1016/s0022-3476(05)80585-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinaemia.

Authors:  W Sperl; R Geiger; H Maurer; C Murr; C Schmoigl; E Steichen-Gersdorf; M Sailer
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Microangiopathic hemolytic anemia, thrombocytopenia, and renal injury during continuous venovenous hemodialysis in a neonate.

Authors:  J R Sherbotie
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  Short-term survival of hyperammonemic neonates treated with dialysis.

Authors:  Stefano Picca; Carlo Dionisi-Vici; Andrea Bartuli; Tommaso De Palo; Francesco Papadia; Giovanni Montini; Marco Materassi; Maria Alice Donati; Enrico Verrina; Maria Cristina Schiaffino; Carmine Pecoraro; Emilia Iaccarino; Enrico Vidal; Alberto Burlina; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

4.  ECMO as a Platform for Rapid Ammonia Removal in a Neonate with Multienzyme Urea Cycle Disorder.

Authors:  Kelechi Ikeri; Vilmaris Quinones Cardona; Abena Hagan-Brown; Megan Young; Michael Schneider; Ogechukwu Menkiti
Journal:  J Extra Corpor Technol       Date:  2020-03

5.  Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism.

Authors:  M C Falk; J F Knight; L P Roy; B Wilcken; D N Schell; A J O'Connell; J Gillis
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

Review 6.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.